Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Health Insurance topic
No spam. Unsubscribe anytime.
Senate amends and advances bill to ease insurance hurdles for advanced metastatic cancer patients
Summary
Senate Bill 422 — designed to limit prior‑authorization requirements and related insurer hurdles for advanced metastatic cancer care — was amended in committee with insurer compromise language and passed second reading as amended.
The Senate advanced a bill intended to ease insurance‑imposed obstacles for patients with advanced metastatic (stage‑4) cancer.
Senate Bill 422, carried by Senator Boldman, would limit certain insurer requirements for coverage of treatments for metastatic cancer. In committee the sponsor and insurers reached a compromise amendment; Senator Usher moved that amendment onto the bill on the floor. Sponsor Boldman said the intent is to ensure patients with limited life expectancy can access appropriate treatments without unnecessary administrative delays.
Committee staff reported a fiscal note of zero for the bill as amended. The Senate adopted the insurer‑sponsor amendment and passed the bill on second reading, 36 yeas to 14 nays.
Senators said the measure reflects a compromise designed to target a narrow population (patients with advanced metastatic disease) and to preserve insurer safeguards while reducing barriers to prescribed cancer therapies. The bill will proceed to additional legislative steps.
